H

Heron Therapeutics

HRTX

2.80000
USD
-0.17
(-5.72%)
مفتوح الان
حجم التداول
36,385
الربح لكل سهم
0
العائد الربحي
0
P/E
-7
حجم السوق
261,627,329
أصول ذات صلة
AMGN
2.78
(0.84%)
335.22 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
I
INO
-0.670
(-6.28%)
10.000 USD
MRNA
-25.020
(-20.99%)
94.160 USD
REGN
13.14
(1.22%)
1,091.19 USD
S
SGEN
0
(0%)
0.000000 USD
VRTX
9.75
(1.97%)
505.40 USD
الأخبار المقالات

العنوان: Heron Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.